The Homeland Security Digital Library (HSDL) maintains a collection of the Centers for Disease Control’s (CDC) Morbidity and Mortality Weekly Report (MMWR), which collects and analyzes data from the United States Department of Health and Human Services (HHS) on epidemiology and public health. Each issue of the MMWR is packed with raw and analyzed public health data and scientific studies from some of the top minds in the United States. Below we highlight some of the most current and informative studies included in their weekly reports.
Here are some important articles you may have missed from Volume 72, Issues 7-10 of the Centers for Disease Control’s Morbidity and Mortality Weekly Report (MMWR) Series.
March 10, 2023 / No.10 Featured Article:
In this report, the CDC used the Behavioral Risk Factor Surveillance System (BRFSS), “a random-digit–dialed annual landline and cellular telephone cross-sectional survey of noninstitutionalized U.S. adults aged ≥18 years,” and studied data regarding subjective cognitive decline (SCD), which is “self-reported memory loss or confusion that is occurring more frequently.” SCD can be a symptom of early-stage dementia. This report reveals racial and educational trends, and provides advice about actions to take for those noticing cognitive declines.
March 3, 2023 / No. 9 Featured Article:
This article discusses the latest information on Mpox medical countermeasures (MCMs) developed for severe cases, and specifically reviews the use of tecovirimat, brincidofovir, cidofovir, trifluridine ophthalmic solution, and vaccinia immune globulin intravenous. It also evaluates “[a]nimal models, MCM use for human cases of related orthopoxviruses, unpublished data, input from clinician experts, and experience during CDC mpox consultations to further develop interim clinical treatments.”
February 24, 2023 / No. 8 Featured Article:
This report used “data from two concurrent studies conducted at Marshfield Clinic Health System (MCHS) in Wisconsin during October 23, 2022–February 10, 2023, to estimate influenza vaccine effectiveness (VE).” It concluded that the latest influenza vaccine was 54% effective for preventing medically attended influenza A infection among persons older than 65 years, and 71% effective for preventing symptomatic influenza A illness among children and adolescents younger than 18 years.
February 17, 2023 / No. 7 Featured Article:
This article discusses the significantly low COVID-19 vaccination coverage in younger children and infants, and provides supporting evidence for the need to vaccinate this age group.
For more information on COVID, visit HSDL’s COVID-19 Resource Archive. You can also find pandemic-related resources in HSDL’s In Focus on Pandemics and Epidemics, and search our statistical resources related to public health.